Hindustan Unilever has submitted the Shareholding Pattern for the Period Ended March 31, 2017. The above information is a part of company’s filings submitted to BSE.
Drug firm Wockhardt has received approval from the US health regulator to market generic version of Wyeth’s Zosyn, used for treating bacterial infections, in the American market. The application for the product to the US Food and Drug Administration (USFDA) was made by the company’s subsidiary Wockhardt Bio AG. Hindustan Unilever (HUL) has commenc..
Hindustan Unilever (HUL) has commenced the commercial production at its new manufacturing unit located at Assam on March 15, 2017. Last year in July, the company had proposed to make an investment of about Rs 1,000 crore towards the setting up of a new manufacturing unit in the vicinity of its existing factory premises in Doom Dooma, Assam. The inv..
Hindustan Unilever has reported results for third quarter ended December 31, 2016. The company has reported 6.82% rise in its net profit at Rs 1037.93 crore for the quarter under review as compared to Rs 971.66 crore for the same quarter in the previous year. However, total income of the company decreased by 1.52% at Rs 8400.38 crore for the quar..
Revenue reduced marginally to stand at Rs. 77059.80 millions during the quarter ended December 2016. The figure stood at Rs. 77639.50 millions during the year-ago period.Profit saw a slight increase of 6.82%to Rs. 10379.30 millions from Rs. 9716.60 millions.Operating profit for the quarter ended December 2016 decreased to 14378.80 millions as comp..
With no major difference for the quarter endedDecember 2016 , the total revenue stood at Rs. 81244.80 millions.A humble growth in net profit of 6.85% reported in the quarter ended December 2016 to Rs. 10379.30 millions from Rs. 9714.00 millions.A decline of 11442.20 millions was observed in the OP in the quarter ended December 2016 from 15704.20 ..
Hindustan Unilever has informed that the Company has not made any allotment of shares under ESOPs during the quarter ended December 31, 2016. Consequently, the requirement of submission of a Certificate from the Statutory Auditors for allotment made under the ESOP Schemes is not applicable for the quarter ended December 31, 2016. The above informat..
Hindustan Unilever has informed that a meeting of the Board of Directors of the Company will be held on January 23, 2017, to consider the unaudited financial results for the quarter ended December 31, 2016 (Q3) along with the limited review report of the auditors for the corresponding period. Pursuant to Clause 3(1) of the Share Dealing Code of the..
GE Power India (GEPIL) has been awarded contracts worth $40 million by Bharat Heavy Electricals (BHEL) to supply components and services for the supercritical steam generator island packages for 2x800 MW coal-based Uppur Thermal Power Project and 1x800MW coal-based North Chennai Supercritical Thermal Power Project Stage-III. Both the thermal power ..
This is to inform the Exchange that the Committee of the Board in its Meeting held on 27.3.2017, has allotted 45,838 Equity Shares of Re. 1/- each under ESOP
This is with reference to our letter dated 18th July, 2016 wherein we had informed the exchanges about Company's decision to set up new manufacturing unit in Assam to augment the production capacity of Personal Care Products of the Company. In this regard, we are pleased to inform you that the Company has commenced the commercial pr..
Hindustan Unilever Ltd has informed BSE that the Committee of the Board in its Meeting held on February 27, 2017, has allotted 29,117 Equity Shares of Re. 1/- each under ESOP, which vide Shareholder’s Resolution dated May 29, 2006 is known as “2006 HLL Performance Share Scheme”, further amended vide Shareholder’s Resolution dated 23rd Jul..
Hindustan Unilever Ltd has informed BSE about : 1. Result Presentation for the period ended December 31, 2016
Hindustan Unilever Ltd has informed BSE the Board of Directors of the Company at its meeting held on January 23, 2017, inter alia, has :- approved the appointment of Mr. Dev Bajpai as Director on the Board of the Company. Mr. Dev Bajpai shall continue to act as the Company Secretary and Compliance Officer of the Company. A copy of..
News Body Follows......